Rob Woestenenk
- Immunology top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 5%
- Oncology top 10%
- Hematology top 10%
- Co-authors
- Hans J. P. M. KoenenIrma JoostenP C van de KerkhofH. Jorn BovenschenP.E.J. van ErpFrank PreijersHarry DolstraWillemijn Hobo
- Topics
- Immune Cell Function and Interaction (8 papers)T-cell and B-cell Immunology (8 papers)CAR-T cell therapy research (5 papers)
- Cited by
- ImmunologyDermatologyHematology
- Partner nations
- NetherlandsUnited StatesSingapore
In The Last Decade
Rob Woestenenk
22 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Immunology 878
- Molecular Biology 348
- Public Health, Environmental and Occupational Health 320
- Oncology 280
- Hematology 125
Countries citing papers authored by Rob Woestenenk
This map shows the geographic impact of Rob Woestenenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Woestenenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Woestenenk more than expected).
Fields of papers citing papers by Rob Woestenenk
This network shows the impact of papers produced by Rob Woestenenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Woestenenk. The network helps show where Rob Woestenenk may publish in the future.
Co-authorship network of co-authors of Rob Woestenenk
This figure shows the co-authorship network connecting the top 25 collaborators of Rob Woestenenk. A scholar is included among the top collaborators of Rob Woestenenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Woestenenk. Rob Woestenenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 54 | |
| 2 | 15 | |
| 3 | 137 | |
| 4 | 112 | |
| 5 | 38 | |
| 6 | 40 | |
| 7 | 15 | |
| 8 | 94 | |
| 9 | 14 | |
| 10 | 177 | |
| 11 | 39 | |
| 12 | 14 | |
| 13 | 334 | |
| 14 | 37 | |
| 15 | 58 | |
| 16 | 133 | |
| 17 | Breast cancer resistance protein 1 (bcrp) and p-glycoprotein (mdr1) are key players in renal regeneration after ischemic injury | 1 |
| 18 | 16 | |
| 19 | 107 | |
| 20 | 12 |
About Rob Woestenenk
Rob Woestenenk is a scholar working on Immunology, Hematology and Oncology, having authored 22 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Immunology (878 citations), Dermatology (100 citations) and Hematology (125 citations). Rob Woestenenk has collaborated with scholars based in Netherlands, United States and Singapore. Frequent co-authors include Hans J. P. M. Koenen, Irma Joosten, P C van de Kerkhof, H. Jorn Bovenschen, P.E.J. van Erp, Frank Preijers, Harry Dolstra, Willemijn Hobo, Robert W. Sauerwein and Anniek B. van der Waart. Their work appears in journals such as Nucleic Acids Research, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.